File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/19466315.2024.2327291
- Scopus: eid_2-s2.0-85190538348
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Implementation of Statistical Innovation in a Pharmaceutical Company
Title | Implementation of Statistical Innovation in a Pharmaceutical Company |
---|---|
Authors | |
Keywords | Collaboration Commercialization Innovation Invention Statistics |
Issue Date | 1-Jan-2024 |
Publisher | Taylor and Francis Group |
Citation | Statistics in Biopharmaceutical Research, 2024 How to Cite? |
Abstract | Innovation, defined as the successful implementation at scale of a new invention, is key for continued success of the drug development enterprise. In this article we focus on statistical innovation in the pharmaceutical industry. We discuss both components, invention and implementation at scale, typically called commercialization, of innovation for statistical methods. These concepts are illustrated using three examples that we successfully implemented in our company. We summarize factors that foster or hinder invention and commercialization. A discussion of the mindset we consider supportive of innovation and how organizational leaders and professional organizations can generate an environment that fosters innovation concludes the article. |
Persistent Identifier | http://hdl.handle.net/10722/350442 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rufibach, Kaspar | - |
dc.contributor.author | Wolbers, Marcel | - |
dc.contributor.author | Devenport, Jenny | - |
dc.contributor.author | Yung, Godwin | - |
dc.contributor.author | Harbron, Chris | - |
dc.contributor.author | Bedding, Alun | - |
dc.contributor.author | Huang, Zhiyue | - |
dc.contributor.author | Lin, Ray | - |
dc.contributor.author | Pang, Herbert | - |
dc.contributor.author | Sabanés Bové, Daniel | - |
dc.contributor.author | Wang, Jianmei | - |
dc.date.accessioned | 2024-10-29T00:31:36Z | - |
dc.date.available | 2024-10-29T00:31:36Z | - |
dc.date.issued | 2024-01-01 | - |
dc.identifier.citation | Statistics in Biopharmaceutical Research, 2024 | - |
dc.identifier.uri | http://hdl.handle.net/10722/350442 | - |
dc.description.abstract | Innovation, defined as the successful implementation at scale of a new invention, is key for continued success of the drug development enterprise. In this article we focus on statistical innovation in the pharmaceutical industry. We discuss both components, invention and implementation at scale, typically called commercialization, of innovation for statistical methods. These concepts are illustrated using three examples that we successfully implemented in our company. We summarize factors that foster or hinder invention and commercialization. A discussion of the mindset we consider supportive of innovation and how organizational leaders and professional organizations can generate an environment that fosters innovation concludes the article. | - |
dc.language | eng | - |
dc.publisher | Taylor and Francis Group | - |
dc.relation.ispartof | Statistics in Biopharmaceutical Research | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Collaboration | - |
dc.subject | Commercialization | - |
dc.subject | Innovation | - |
dc.subject | Invention | - |
dc.subject | Statistics | - |
dc.title | Implementation of Statistical Innovation in a Pharmaceutical Company | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/19466315.2024.2327291 | - |
dc.identifier.scopus | eid_2-s2.0-85190538348 | - |
dc.identifier.eissn | 1946-6315 | - |
dc.identifier.issnl | 1946-6315 | - |